Lilia-Celine Lozada
Stock Analyst at JP Morgan
(1.79)
# 3,341
Out of 5,135 analysts
9
Total ratings
40%
Success rate
8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lilia-Celine Lozada
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NVST Envista Holdings | Maintains: Neutral | $22 → $26 | $28.07 | -7.37% | 2 | Feb 6, 2026 | |
| ATRC AtriCure | Maintains: Overweight | $42 → $48 | $32.97 | +45.59% | 4 | Dec 16, 2025 | |
| XRAY DENTSPLY SIRONA | Maintains: Neutral | $14 → $12 | $12.44 | -3.54% | 1 | Nov 7, 2025 | |
| TMCI Treace Medical Concepts | Downgrades: Underweight | $8 → $5 | $1.83 | +173.22% | 2 | Nov 7, 2025 |
Envista Holdings
Feb 6, 2026
Maintains: Neutral
Price Target: $22 → $26
Current: $28.07
Upside: -7.37%
AtriCure
Dec 16, 2025
Maintains: Overweight
Price Target: $42 → $48
Current: $32.97
Upside: +45.59%
DENTSPLY SIRONA
Nov 7, 2025
Maintains: Neutral
Price Target: $14 → $12
Current: $12.44
Upside: -3.54%
Treace Medical Concepts
Nov 7, 2025
Downgrades: Underweight
Price Target: $8 → $5
Current: $1.83
Upside: +173.22%